Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

User Experience With DuraTouch® in Patients With Type 1 or Type 2 Diabetes

NCT: NCT07052292 · COMPLETED

NCT IDNCT07052292

StatusCOMPLETED

Start Date2025-07-01

Completion2026-01-09

Brief Summary

This study looks at overall impact of the use of DuraTouch® in terms of ease, convenience to use and satisfaction in participants with either type 1 or type 2 diabetes.The study will last for about 12 weeks.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑